荧光法研究偏钒酸钠与牛血清白蛋白的相互作用

本文用荧光光谱和紫外可见吸收光谱研究了在模拟人体生理条件下，偏钒酸钠与牛血清白蛋白(BSA)结合反应的特征，研究了紫外灯(253.7 nm)照射对偏钒酸钠与BSA结合的影响。紫外吸收光谱显示，加入偏钒酸钠后，牛血清白蛋白的紫外吸收降低，表明偏钒酸钠与BSA形成了缔合物。荧光猝灭光谱显示偏钒酸钠对牛血清白蛋白有较强的荧光猝灭作用，荧光猝灭机理符合静态机制。缔合物的稳定常数分别为：K_s=0.357×10⁴(25 ℃)，K_{s相似文献}   

稀土金属离子与人血清白蛋白的相互作用

本文用荧光光谱、紫外-可见吸收光谱法和循环伏安法研究了稀土金属离子Eu(Ⅲ)、Pr(Ⅲ)与人血清白蛋白(HSA)的相互作用。实验发现：Eu(Ⅲ)和Pr(Ⅲ)对HSA有较强的荧光猝灭作用。用Stern-Volmer方程分别对实验数据进行处理，结果发现：HSA与Eu(Ⅲ)、Pr(Ⅲ)发生反应生成了新的复合物，发生了分子内的非辐射能量转移。Eu(Ⅲ)、Pr(Ⅲ)对HAS的荧光猝灭作用，属于静态荧光猝灭。荧光猝灭图表明：Eu³⁺和Pr³⁺在HSA分子中至少有两类结合位点，Eu³⁺与HSA形成2.76∶1的复合物，结合常数lgK分别为12.03和9.05；Pr³⁺与HSA形成2.2∶1的复合物，结合常数lgK分别为9.89和6.97。同时用圆二色谱及同步荧光光谱法探讨了 Eu(Ⅲ)和Pr(Ⅲ)对HSA构象的影响。     

4',5,7-三羟基二氢黄酮与人血清白蛋白相互作用的光谱学研究

应用紫外吸收光谱、荧光光谱和红外光谱等方法对人血清白蛋白(HSA)与4',5,7-三羟基二氢黄酮(naringenin, NAR)相互作用的机理进行了研究. 紫外光谱显示, 在生理pH下NAR分子中A环7位的酚羟基发生部分解离, 7位酚羟基的解离使A环与B环上羰基形成的共轭体系的紫外吸收峰发生明显红移; 药物与蛋白质的相互作用使该谱带发生了进一步的红移, 说明该共轭体系参与了与蛋白质的相互作用. 在药物与蛋白质浓度比(c_NAR/c_HSA)为0.1～10 的范围内, NAR在HSA上只有一个结合位点(可能位于site I), 结合常数为1.27×10⁵ L•mol^－1 (n＝5, RSD小于5%). 研究了不同pH值条件下药物对蛋白质荧光猝灭的影响, 发现药物分子中的没有解离的活性基团在结合过程中发挥着主导作用. 在缓冲水溶液和重水溶液中分别测定了与药物作用前后蛋白质二级结构的变化. 随着药物浓度的增加, NAR和HSA之间的相互作用使HSA的α-螺旋结构的含量明显降低, 而β-折叠和β-转角结构的含量增加, 无轨结构在药物浓度较高时也有少量的增加. 结合紫外吸收光谱、荧光光谱和红外光谱结果, 探讨了HSA与NAR相互作用的模式.     

健那绿B的荧光猝灭研究及作为核酸测定探针的应用

用紫外可见光谱、稳态荧光发射及荧光寿命测定研究了核酸猝灭十二烷基磺酸钠胶束中的健那绿荧光。水溶液中弱的健那绿荧光在十二烷基磺酸钠胶束中被大大加强，其最大发射从425纳米移至410纳米，核酸的加入将猝灭健那绿的荧光，当健那绿浓度为2.5×10^–5 mol•L^-1时，荧光猝灭(F₀/F)分别与小牛胸腺DNA及鱼精DNA在2.4×10^–8 到 1.08×10^–7及 1.9×10^–8 到 3.8×10^–8 mol•L^-1范围内成正比, 检测限分别为1.3×10^–8 mol•L^-1 (小牛胸腺DNA)及6.3×10^–9 mol•L^-1 (鱼精DNA)。当DNA浓度较高时, 将系统偏离Stern-Volmer方程。这是因为动态猝灭和静态猝灭同时存在。方法已应用于鸡血提取液中DNA的测定, 测定结果与紫外法一致。     

加替沙星与牛血清白蛋白结合作用的光谱学研究

通过荧光猝灭光谱研究了15℃和37℃下水溶液中加替沙星（HGA）与牛血清白蛋白(BSA)的结合作用。由Stern-Volmer曲线计算出双分子猝灭速率常数分别为：K_q=9.28×10¹²L·mol^－1·s^－1(15℃)，K_q=8.51×10¹²L·mol^-1·s^-1 (37 ℃)。结果显示，HGA对BSA的荧光猝灭机理是一种静态猝灭过程。本文获得的热力学参数表明HGA主要以静电引力与BSA结合。HGA的浓度与BSA的荧光强度之间关系的研究表明，HGA与BSA按1 ：1摩尔比结合，结合反应的平衡常数K₀= 6.80×10⁴ L·mol^－1。另外，通过Förster原理计算了HGA与BSA的结合距离及能量转移效率。     

Cu2+与烟草多酚氧化酶相互作用研究

本文通过酶活性测定，荧光光谱和紫外光谱研究了外加Cu²⁺与烟草多酚氧化酶(简称PPO)的相互作用。结果表明，微量铜的加入能增加酶的活性，[Cu²⁺]/[PPO]为0.20左右时酶活性最大，[Cu²⁺]/[PPO]为0.91时，Cu²⁺开始表现出对PPO活性的抑制;Cu²⁺对PPO内源荧光的猝灭机制属于形成络合物所引起的静态猝灭，猝灭常数K_sv为8.0375×10³L·mol^-1;Cu²⁺的加入使PPO蛋白质分子构象发生变化，α-螺旋含量增加，多肽链及Trp和Tyr残基的芳杂环进一步向分子内收缩，疏水基团之间的疏水作用增强。     

5,7-二羟基-4'-甲氧基二氢黄酮与牛血清白蛋白的相互作用研究

应用荧光光谱、紫外吸收光谱和核磁共振波谱研究了5,7-二羟基-4'-甲氧基二氢黄酮(ISO)与牛血清白蛋白(BSA)分子间的相互作用. 研究表明: ISO对BSA内源性荧光的猝灭机制属于ISO和BSA形成化合物所引起的静态猝灭; 二者的结合常数为7.41×10¹¹ L/mol, 结合位点数为1.98. ISO与BSA作用的活性部位为其分子内的7-OH和5-OH, 且7-OH活性强于5-OH, 并且随着ISO浓度增大, BSA的构象发生了变化.     

烟碱与人血清蛋白相互作用的光谱研究

在0.1 mol/L的磷酸氢二钠-柠檬酸体系中,采用荧光光谱、紫外吸收光谱研究了人血清蛋白与烟碱的相互作用.荧光滴定表明这种相互作用使HSA的内源荧光猝灭.通过猝灭常数、结合常数和结合位点数的计算,证明了这种猝灭为静态猝灭机制.尼古丁和HSA形成11稳定复合物;考察不同温度和酸度下的猝灭作用,进一步证实其静态猝灭行为和疏水作用机制.紫外吸收光谱和同步荧光光谱表明,相互作用引起HSA构象变化,而同步荧光光谱提示结合位点更接近于色氨酸.     

肉桂酸与牛血清白蛋白相互作用及酒精的影响

用荧光光谱法研究了肉桂酸与牛血清白蛋白(BSA)在生理条件下的相互作用. 实验结果表明, 肉桂酸与BSA能形成1:1复合物, 荧光猝灭属于静态猝灭过程; 与BSA分子间主要的结合作用力为疏水作用; 310 K 下结合常数和结合位点数分别为3.07×10⁴ L·mol-1和1.10; 肉桂酸使BSA的构象发生了变化; 另外, 酒精的加入使其结合常数和结合位点数减小.     

荧光法研究3-氨基苯硼酸与牛血清白蛋白间的相互作用

为了了解分子印迹反应的机理和最适宜的反应条件, 应用荧光猝灭法研究了3-氨基苯硼酸(APBA)与牛血清白蛋白(BSA)的相互作用, 二者的反应受到体系pH值、离子强度等关键因素的影响. 实验结果表明: 适宜的离子强度和pH值为6.25时, APBA与BSA的色氨酸残基的荧光猝灭反应的物质的量比为2∶1, 表观结合常数K_A＝1.0×10¹¹ L²• mol^－2, 说明二者间形成了较强的化学键. 通过上述研究, 明晰了3-氨基苯硼酸与牛血清白蛋白之间的作用机理, 有助于分离或富集蛋白质中BSA组分, 从而能够改进印迹和洗脱的效率.     

Study on the Interaction of Nd3+ with Human Serum Albumin at Molecular Level

Neodymium is applied widely in agriculture to improve crop nutrition and incidentally in fertilizers, yet little is known of its effect on the biological function of human serum albumin (HSA). The interaction of Nd³⁺ to HSA has been investigated mainly by fluorescence spectra, UV–vis absorption spectra and circular dichroism (CD) under simulative physiological conditions. Fluorescence data revealed that the quenching mechanism of HSA by Nd³⁺ was a static quenching process and the binding constant is 5.71 × 10⁴ L mol^‐1 and the number of binding sites is 1 at 292 K. The thermodynamic parameters (ΔH⁰ = ‐20.79 kJ mol^‐1, ΔG⁰ = ‐26.58 kJ mol^‐1, and ΔS⁰ = 19.85 J mol^‐1 K^‐1) indicate that electrostatic effect between the protein and Nd³⁺ is the main binding force. The distance r = 2.91 nm between donor (HSA) and acceptor (Nd³⁺) was obtained according to Förster's nonradiative energy transfer. In addition, UV–vis, CD and synchronous fluorescence results showed that the addition of Nd³⁺ changed the conformation of HSA.     

长春新碱与人血清白蛋白的相互作用研究

利用荧光和圆二色光谱研究了长春新碱(VCR)与人血清白蛋白(HSA)之间的相互作用. 通过荧光猝灭测得在288, 298和308 K时, VCR与HSA的结合常数K分别为2.14×10⁴, 1.73×10⁴ 和1.35×10⁴ L•mol^－1, 表明VCR与HSA间具有较强的结合作用, 属于静态猝灭. 计算出焓变(ΔH)为 －17.38 kJ•mol^－1, 熵变(ΔS)为22.62 J•mol^－1•K^－1, 结合分子模型理论计算的结果, 表明VCR与HSA相互作用时在色氨酸(Trp) 214残基和VCR分子中吲哚基间作用力以疏水作用力为主, 但在 VCR和HSA 分子间以静电引力为主. 圆二色光谱(CD)的数据表明相互作用后HSA的二级结构发生了改变：HSA的α-螺旋的含量从51.7%下降到32.9%, β-折叠的含量增加了9.2%.     

Insight into the binding evaluation of two antitumor Pd(II) complexes with human serum albumin

The interaction between two novel water-soluble palladium(II) complexes (Pd(bpy)(pyr-dtc)]NO₃, complex I and ([Pd(phen)(pyr-dtc)]NO₃, complex II, where bpy = 2,2′-bipyridine, phen = 1,10-phenanthroline and pyr-dtc = pyrrolidinedithiocarbame) and human serum albumin (HSA) was investigated by fluorescence quenching spectroscopy, synchronous, fluorescence resonance energy transfer (FRET) and three-dimensional fluorescence combined with UV–Vis absorption spectroscopy and circular dichroism technique under simulative physiological conditions. Fluorescence analysis demonstrated that the quenching mechanism of HSA by Pd(II) complexes was static fluorescence quenching and hydrogen bonds and van der Waals interactions were the main intermolecular force based on thermodynamic data. The HSA–Pd(II) complex interaction had a high affinity of 10⁵ M^?1, and the number of binding sites n is almost 1. The results of synchronous fluorescence, three-dimensional fluorescence spectra, UV–Vis absorption and CD spectroscopy indicated that these two complexes may induce the microenvironment around the tryptophan residues and the conformation of human serum albumin. The binding distance (r) in the interaction between Pd(II) complex and HSA was estimated by the efficiency of fluorescence resonance energy transfer (FRET). Furthermore, results from multiple spectroscopic studies are consistent and indicate that the antitumor Pd(II) complexes can efficiently bind with human serum albumin molecules, providing a reasonable model that can help in understanding the design, transportation and toxic effects of anticancer agents.     

Synthesis,structural determination and HSA interaction studies of a new water-soluble Cu(II) complex derived from 1,10-phenanthroline and ranitidine drug

A new water-soluble Cu(II) complex containing ranitidine drug and 1,10-phenanthroline was synthesized and characterized by elemental analysis, molar conductivity, spectroscopic and computational methods. In vitro human serum albumin (HSA)-interaction studies of Cu(II) complex were performed by employing fluorescence spectroscopy in combination with UV–vis absorption and circular dichroism (CD) spectroscopies. The results of fluorescence titration showed that Cu(II) complex strongly quenched the intrinsic fluorescence of HSA through a static quenching mechanism with an intrinsic binding constant (6.05 × 10⁴ M^?1) at 286 K. The thermodynamic parameters ΔG, ΔH, and ΔS at different temperatures were calculated and suggested that the hydrophobic and hydrogen bonding interactions play major roles in Cu(II) complex-HSA association. The displacement experiments using warfarin and ibuprofen as site I and II probes proved that the Cu(II) complex could bind to site I (subdomain IIA) of HSA. Finally, CD spectra indicated that the interaction of the Cu(II) complex with HSA leads to an increase in the α-helical content. The main result of this study was the finding that the binding affinity of the Cu(II) complex to HSA is three orders of magnitude stronger than that of ranitidine drug.     

Investigating the interaction of juglone (5-hydroxy-1, 4-naphthoquinone) with serum albumins using spectroscopic and in silico methods

The interaction between juglone at the concentration range of 10–110 µM and bovine serum albumin (BSA) or human serum albumin (HSA) at the constant concentration of 11 µM was investigated by fluorescence and UV absorption spectroscopy under physiological-like condition. Performing the experiments at different temperatures showed that the fluorescence intensity of BSA/HSA was decreased in the presence of juglone by a static quenching mechanism due to the formation of the juglone–protein complex. The binding constant for the interaction was in the order of 10³ M^?1, and the number of binding sites for juglone on serum albumins was determined to be equal to one. The thermodynamic parameters including enthalpy (ΔH), entropy (ΔS) and Gibb’s free energy (ΔG) changes were obtained by using the van’t Hoff equation. These results indicated that van der Waals force and hydrogen bonding were the main intermolecular forces stabilizing the complex in a spontaneous association reaction. Moreover, the interaction of BSA/HSA with juglone was verified by UV absorption spectra and molecular docking. The results of synchronous fluorescence, UV–visible and CD spectra demonstrated that the binding of juglone with BSA/HSA induces minimum conformational changes in the structure of albumins. The increased binding affinity of juglone to albumin observed in the presence of site markers (digoxin and ibuprofen) excludes IIA and IIIA sites as the binding site of juglone. This is partially in agreement with the results of molecular docking studies which suggests sub-domain IA of albumin as the binding site.     

Human serum albumin binding studies of a new platinum(IV) complex containing the drug pregabalin: experimental and computational methods

A new platinum(IV) complex, [Pt(en)(Cl)₂(Pregabalin)₂], containing the drug pregabalin was synthesized and characterized by elemental analysis, FT-IR, ¹H NMR, mass spectrum, thermogravimetric analysis (TGA), molecular docking and RHF/PM6 method. Also, the interaction of Pt(IV) complex with human serum albumin (HSA) was studied by using UV–vis, fluorometric, circular dichroism (CD) spectroscopies and molecular docking techniques. The results demonstrated that the binding of the complex to HSA caused strong fluorescence quenching of HSA through static quenching mechanism. Hydrogen bonds and van der Waals contacts are the major forces in the stability of protein-Pt(IV) complex and the process of the binding of complex with HSA was enthalpy driven (ΔH = –105.8?kJ·mol^?1). The results of CD and UV–vis spectroscopy indicated that the binding of the complex to HSA caused conformational changes in HSA. In addition, the study of molecular docking and RHF/PM6 method confirm the experimental results with respect to the mechanism of binding.     

Characterization of the interaction between a platinum(II) complex and human serum albumin: spectroscopic analysis and molecular docking

In this study, the interaction between (2,2?-bipyridine)(pyrrolidinedithiocarbamato) platinum(II) nitrate, [Pt(bpy)(pyr-dtc]NO₃, and human serum albumin (HSA) was investigated by various spectroscopic methods (UV–vis, fluorescence, CD and FT-IR) and molecular docking technique at three temperatures. UV–vis absorption spectroscopy showed that Pt(II) complex can denature the protein at moderate concentrations. The results of emission quenching at two temperatures has revealed that the quenching mechanism of Pt(II) complex with HSA was static quenching mechanism. Binding constants (K), binding site number (n) and corresponding thermodynamic parameters ?G?, ?H? and ?S? were calculated and revealed that hydrophobic forces played a major role when Pt(II) complex interacted with HSA. The binding distance (r) between above complex and HSA based on Förster?s theory of non-radiation energy transfer was calculated as 3.22 nm. Alterations of HSA secondary structure induced by complex were confirmed by FT-IR and CD measurements. Also, a molecular docking study was performed for identification of key structural features of binding of the Pt complex into the receptor and predicting bioactive conformers. Our results may provide valuable information to understand the mechanistic pathway of drug delivery and to pharmacological behavior of drug.     

Norfloxacin La(III)-based complex: synthesis,characterization, and DNA-binding studies

A La(III) complex, [La^IIICl₂(NOR)₂]Cl (2), containing norfloxacin (NOR) (1), a synthetic fluoroquinolone antibacterial agent, has been synthesized and characterized by elemental analysis, IR, UV–vis spectra and ¹H NMR spectroscopy, and molar conductance measurements. The interaction between 2 and CT-DNA was investigated by steady-state absorption and fluorescence techniques in different pH media, and showed that 2 could bind to CT-DNA presumably via non-intercalative mode and the La(III) complex showed moderate ability to bind CT-DNA compared to other La(III) complexes. The binding site number n, and apparent binding constant K_A, corresponding thermodynamic parameters ΔG^#, ΔH^#, ΔS^# at different temperatures were calculated. The binding constant (K_A) values are 0.23 ± 0.05, 0.56 ± 0.05, and 0.18 ± 0.08 × 10⁵ L mol^?1 for pH 4, 7, and 11, respectively. It was also found that the fluorescence quenching mechanism of CT-DNA by La(III) complex was a static quenching process.     

Synthesis,characterization, HSA interaction,and antibacterial activity of a new water-soluble Pt(II) complex containing the drug cephalexin

Abstract

A new water-soluble platinum(II) complex, [Pt(CEX)Cl(DMSO)]Cl (CEX is cephalexin), was synthesized and characterized by physicochemical, spectroscopic, and computational methods. Multispectroscopic techniques were used to investigate the interaction of Pt(II) complex with human serum albumin (HSA) under the physiological conditions. The results of fluorescence titration indicated that the binding of the Pt(II) complex to HSA induced fluorescence quenching through static quenching mechanism with binding constant of 1.24?×?10⁴?M^?1 at 298?K. The thermodynamic parameters at different temperatures indicated that van der Waals forces, hydrogen bonds, and electrostatic forces play major roles in the stability of Pt(II) complex–HSA association. The displacement experiments using the site probes warfarin and ibuprofen substantiated that Pt(II) complex could bind to both site I and II of HSA. Furthermore, UV–Vis and fluorescence spectra were used to investigate the conformational changes of HSA molecule with the addition of Pt(II) complex. The binding constant of Pt(II) complex is more than two orders of magnitude higher than the corresponding value of cephalexin. These results indicate that the binding affinity of Pt(II) complex is stronger than the free drug. In addition, the antibacterial study showed that the MIC of platinum complex of cephalexin for variety of organisms was lower than free cephalexin.